These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8702254

  • 1. p53 protein expression in human breast carcinoma: lack of prognostic potential for recurrence of the disease.
    Katoh A, Breier S, Stemmler N, Specht S, Blanock K, D'Amico F.
    Anticancer Res; 1996; 16(3A):1301-4. PubMed ID: 8702254
    [Abstract] [Full Text] [Related]

  • 2. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG.
    Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900
    [Abstract] [Full Text] [Related]

  • 3. p53 expression in breast cancer related to prognostic factors.
    Ciesielski D, Dziewulska-Bokiniec A, Zółtowska A, Roszkiewicz A, Kopacz A, Wojtacki J.
    Neoplasma; 1995 Mar 01; 42(5):235-7. PubMed ID: 8552201
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 01; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 5. Studies on p53 immunolocalisation in breast cancer and its prognostic significance.
    Meenakshi A, Manoharan V.
    Hum Antibodies; 1999 Jan 01; 9(3):171-6. PubMed ID: 10690631
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: influence on metastasis-free survival.
    Hanzal E, Gitsch G, Kohlberger P, Dadak C, Miechowiecka N, Breitenecker G.
    Anticancer Res; 1992 Jan 01; 12(6B):2325-9. PubMed ID: 1295480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L, Baker H, Sinowatz F.
    Anticancer Res; 2001 Jan 01; 21(1B):743-8. PubMed ID: 11299837
    [Abstract] [Full Text] [Related]

  • 9. Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
    Amornmarn R, Bui MM, Prempree TB, Masood S.
    Ann Clin Lab Sci; 2000 Jan 01; 30(1):33-40. PubMed ID: 10678581
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor expression in male breast carcinoma: lack of clinicopathological association.
    Pich A, Margaria E, Chiusa L, Candelaresi G, Dal Canton O.
    Br J Cancer; 1999 Feb 12; 79(5-6):959-64. PubMed ID: 10070897
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers.
    Peyrat JP, Vanlemmens L, Fournier J, Huet G, Révillion F, Bonneterre J.
    Clin Cancer Res; 1998 Jan 12; 4(1):189-96. PubMed ID: 9516970
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inverse correlation between the expression of O6-methylguanine-DNA methyl transferase (MGMT) and p53 in breast cancer.
    Osanai T, Takagi Y, Toriya Y, Nakagawa T, Aruga T, Iida S, Uetake H, Sugihara K.
    Jpn J Clin Oncol; 2005 Mar 12; 35(3):121-5. PubMed ID: 15741301
    [Abstract] [Full Text] [Related]

  • 17. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.
    Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC.
    Cancer Res; 1994 Jul 15; 54(14):3752-7. PubMed ID: 8033095
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 15; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 19. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.
    Cancer; 2004 Jun 01; 100(11):2317-27. PubMed ID: 15160334
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.